secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sarepta Therapeutics, Inc. (SRPT)
CIK:        0000873303
Form:       8-K
Filed at:   2022-09-19T23:59:59+00:00
Accession:  0001193125-22-247130
Event type: debt
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 1.02, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sarepta Therapeutics issues $1.13B in convertible notes, repays $585.5M term loan
--------------------------------------------------------------------------------

- Issued $1.13B aggregate principal of 1.25% Convertible Senior Notes due 2027 to initial purchasers including Goldman Sachs and J.P. Morgan.
- Sold $20M in notes to Michael A. Chambers Living Trust, an affiliate of board member Michael Chambers.
- Prepaid $585.5M term loan from BioPharma Credit, including $7M prepayment premium, terminating the Loan Agreement.
- Used proceeds to repurchase $150.6M of existing 1.50% Convertible Senior Notes due 2024.
- Entered capped call transactions with five counterparties to reduce potential dilution upon conversion of the notes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/873303/000119312522247130/0001193125-22-247130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/873303/000119312522247130/d357082d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-247130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer